BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 17161244)

  • 1. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function.
    Steen H; Giannitsis E; Futterer S; Merten C; Juenger C; Katus HA
    J Am Coll Cardiol; 2006 Dec; 48(11):2192-4. PubMed ID: 17161244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T.
    Giannitsis E; Steen H; Kurz K; Ivandic B; Simon AC; Futterer S; Schild C; Isfort P; Jaffe AS; Katus HA
    J Am Coll Cardiol; 2008 Jan; 51(3):307-14. PubMed ID: 18206741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
    J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months.
    Bøhmer E; Hoffmann P; Abdelnoor M; Seljeflot I; Halvorsen S
    Cardiology; 2009; 113(3):207-12. PubMed ID: 19218804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.
    Di Chiara A; Dall'Armellina E; Badano LP; Meduri S; Pezzutto N; Fioretti PM
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):587-92. PubMed ID: 20588136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.
    Hallén J; Buser P; Schwitter J; Petzelbauer P; Geudelin B; Fagerland MW; Jaffe AS; Atar D
    Am J Cardiol; 2009 Dec; 104(11):1472-7. PubMed ID: 19932777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction.
    Andrassy M; Volz HC; Riedle N; Gitsioudis G; Seidel C; Laohachewin D; Zankl AR; Kaya Z; Bierhaus A; Giannitsis E; Katus HA; Korosoglou G
    J Intern Med; 2011 Sep; 270(3):245-53. PubMed ID: 21362071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
    Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and extent of cardiac magnetic resonance microvascular obstruction in reperfused non-ST-elevated myocardial infarction and correlation with infarct size and myocardial enzyme release.
    Mewton N; Bonnefoy E; Revel D; Ovize M; Kirkorian G; Croisille P
    Cardiology; 2009; 113(1):50-8. PubMed ID: 18984954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic diastolic dysfunction and magnetic resonance infarct size in healed myocardial infarction treated with primary angioplasty.
    Barbieri A; Bursi F; Politi L; Rossi L; Fiocchi F; Ligabue G; Pingitore A; Positano V; Torricelli P; Modena MG
    Echocardiography; 2008 Jul; 25(6):575-83. PubMed ID: 18422674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction.
    Rasoul S; Nienhuis MB; Ottervanger JP; Slingerland RJ; de Boer MJ; Dambrink JH; Ernst NM; Hoorntje JC; Gosselink AT; Suryapranata H; Zijlstra F; van 't Hof AW
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):281-6. PubMed ID: 16824278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging.
    Ripa RS; Nilsson JC; Wang Y; Søndergaard L; Jørgensen E; Kastrup J
    Am Heart J; 2007 Nov; 154(5):929-36. PubMed ID: 17967600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serial measurements of infarct size and left ventricular ejection fraction by contrast-enhanced cardiac magnetic resonance imaging and electrocardiographic QRS scoring in reperfused anterior ST-elevation myocardial infarction.
    Weir RA; Martin TN; Murphy CA; Petrie CJ; Clements S; Steedman T; Dargie HJ; Wagner GS
    J Electrocardiol; 2010; 43(3):230-6. PubMed ID: 20116803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
    Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
    Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
    Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
    J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion.
    Hedström E; Aström-Olsson K; Ohlin H; Frogner F; Carlsson M; Billgren T; Jovinge S; Cain P; Wagner GS; Arheden H
    Scand Cardiovasc J; 2007 Jan; 41(1):44-50. PubMed ID: 17365977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.
    Pride YB; Giuseffi JL; Mohanavelu S; Harrigan CJ; Manning WJ; Gibson CM; Appelbaum E
    Am J Cardiol; 2010 Sep; 106(5):635-40. PubMed ID: 20723637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Appelbaum E; Abraham JM; Pride YB; Harrigan CJ; Peters DC; Biller LH; Manning WJ; Gibson CM
    Am Heart J; 2009 Jul; 158(1):84-91. PubMed ID: 19540396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.